Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 5
2008 3
2009 2
2010 3
2011 6
2012 4
2013 8
2014 6
2015 8
2016 6
2017 9
2018 7
2019 17
2020 26
2021 35
2022 42
2023 38
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators. Perkovic V, et al. N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14. N Engl J Med. 2019. PMID: 30990260 Free article. Clinical Trial.
Hemodialysis.
Tavares AR Jr, Vieira CP, Souza PA. Tavares AR Jr, et al. Among authors: souza pa. N Engl J Med. 2011 Feb 10;364(6):584-5; author reply 585. doi: 10.1056/NEJMc1013968. N Engl J Med. 2011. PMID: 21306269 No abstract available.
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zhou Z, Jardine MJ, Li Q, Neuen BL, Cannon CP, de Zeeuw D, Edwards R, Levin A, Mahaffey KW, Perkovic V, Neal B, Lindley RI; CREDENCE Trial Investigators*. Zhou Z, et al. Stroke. 2021 May;52(5):1545-1556. doi: 10.1161/STROKEAHA.120.031623. Epub 2021 Apr 20. Stroke. 2021. PMID: 33874750 Free PMC article. Clinical Trial.
A host defense peptide mimetic, brilacidin, potentiates caspofungin antifungal activity against human pathogenic fungi.
Dos Reis TF, de Castro PA, Bastos RW, Pinzan CF, Souza PFN, Ackloo S, Hossain MA, Drewry DH, Alkhazraji S, Ibrahim AS, Jo H, Lightfoot JD, Adams EM, Fuller KK, deGrado WF, Goldman GH. Dos Reis TF, et al. Among authors: souza pfn. Nat Commun. 2023 Apr 12;14(1):2052. doi: 10.1038/s41467-023-37573-y. Nat Commun. 2023. PMID: 37045836 Free PMC article.
Nano-Nutraceuticals for Health: Principles and Applications.
Magne TM, Alencar LMR, Carneiro SV, Fechine LMUD, Fechine PBA, Souza PFN, Portilho FL, de Barros AODS, Johari SA, Ricci-Junior E, Santos-Oliveira R. Magne TM, et al. Among authors: souza pfn. Rev Bras Farmacogn. 2023;33(1):73-88. doi: 10.1007/s43450-022-00338-7. Epub 2022 Nov 23. Rev Bras Farmacogn. 2023. PMID: 36466145 Free PMC article. Review.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
Systematic review of antiprotozoal potential of antimicrobial peptides.
Santos FA, Cruz GS, Vieira FA, Queiroz BRS, Freitas CDT, Mesquita FP, Souza PFN. Santos FA, et al. Among authors: souza pfn. Acta Trop. 2022 Dec;236:106675. doi: 10.1016/j.actatropica.2022.106675. Epub 2022 Aug 31. Acta Trop. 2022. PMID: 36057367 Review.
205 results